Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
1999 2
2001 2
2002 4
2003 4
2004 4
2005 7
2006 2
2007 5
2008 6
2009 2
2010 4
2011 5
2012 6
2013 3
2014 4
2015 5
2016 7
2017 2
2018 3
2019 3
2020 2
2021 4
2022 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy.
Wei J, Long L, Zheng W, Dhungana Y, Lim SA, Guy C, Wang Y, Wang YD, Qian C, Xu B, Kc A, Saravia J, Huang H, Yu J, Doench JG, Geiger TL, Chi H. Wei J, et al. Among authors: geiger tl. Nature. 2019 Dec;576(7787):471-476. doi: 10.1038/s41586-019-1821-z. Epub 2019 Dec 11. Nature. 2019. PMID: 31827283 Free PMC article.
T cell metabolism in homeostasis and cancer immunity.
Wei J, Zheng W, Chapman NM, Geiger TL, Chi H. Wei J, et al. Among authors: geiger tl. Curr Opin Biotechnol. 2021 Apr;68:240-250. doi: 10.1016/j.copbio.2021.02.003. Epub 2021 Mar 4. Curr Opin Biotechnol. 2021. PMID: 33676144 Free PMC article. Review.
Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling.
Koelink PJ, Bloemendaal FM, Li B, Westera L, Vogels EWM, van Roest M, Gloudemans AK, van 't Wout AB, Korf H, Vermeire S, Te Velde AA, Ponsioen CY, D'Haens GR, Verbeek JS, Geiger TL, Wildenberg ME, van den Brink GR. Koelink PJ, et al. Among authors: geiger tl. Gut. 2020 Jun;69(6):1053-1063. doi: 10.1136/gutjnl-2019-318264. Epub 2019 Sep 10. Gut. 2020. PMID: 31506328 Free PMC article.
Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL.
Talleur AC, Qudeimat A, Métais JY, Langfitt D, Mamcarz E, Crawford JC, Huang S, Cheng C, Hurley C, Madden R, Sharma A, Suliman A, Srinivasan A, Velasquez MP, Obeng EA, Willis C, Akel S, Karol SE, Inaba H, Bragg A, Zheng W, Zhou SM, Schell S, Tuggle-Brown M, Cullins D, Patil SL, Li Y, Thomas PG, Zebley C, Youngblood B, Pui CH, Lockey T, Geiger TL, Meagher MM, Triplett BM, Gottschalk S. Talleur AC, et al. Among authors: geiger tl. Blood Adv. 2022 Nov 8;6(21):5737-5749. doi: 10.1182/bloodadvances.2021006293. Blood Adv. 2022. PMID: 35446934 Free PMC article. Clinical Trial.
Development and maturation of natural killer cells.
Geiger TL, Sun JC. Geiger TL, et al. Curr Opin Immunol. 2016 Apr;39:82-9. doi: 10.1016/j.coi.2016.01.007. Epub 2016 Feb 2. Curr Opin Immunol. 2016. PMID: 26845614 Free PMC article. Review.
Modulation of PI3K signaling to improve CAR T cell function.
Zheng W, Jones LL, Geiger TL. Zheng W, et al. Among authors: geiger tl. Oncotarget. 2018 Nov 9;9(88):35807-35808. doi: 10.18632/oncotarget.26334. eCollection 2018 Nov 9. Oncotarget. 2018. PMID: 30533195 Free PMC article. No abstract available.
82 results